{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:33:15Z","timestamp":1768591995577,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.07.027","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T23:12:06Z","timestamp":1533165126000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-9853","authenticated-orcid":false,"given":"Dina","family":"Ragab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Mobasher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Shabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.07.027_b0005","doi-asserted-by":"crossref","first-page":"A288","DOI":"10.1016\/j.autrev.2009.11.019","article-title":"The environment, ge, o-epidemiology, and autoimmune disease: rheumatoid arthritis","volume":"9","author":"Tobon","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2018.07.027_b0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2018.07.027_b0015","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Eng. J. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.cyto.2018.07.027_b0020","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis","volume":"51","author":"Choy","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2018.07.027_b0025","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","article-title":"Insights into IL-37, the role in autoimmune diseases","volume":"14","author":"Xu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2018.07.027_b0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apm.12467","article-title":"Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis","volume":"123","author":"Yang","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.cyto.2018.07.027_b0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0961203316646462","article-title":"Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients","volume":"25","author":"Wu","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.cyto.2018.07.027_b0040","doi-asserted-by":"crossref","first-page":"11601","DOI":"10.1038\/s41598-017-11397-5","article-title":"IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells","volume":"7","author":"Ding","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2018.07.027_b0045","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1038\/ncomms5711","article-title":"IL-37 protects against obesity-induced inflammation and insulin resistance","volume":"5","author":"Ballak","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2018.07.027_b0050","doi-asserted-by":"crossref","first-page":"136329","DOI":"10.1155\/2014\/136329","article-title":"The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease","volume":"2014","author":"Li","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2018.07.027_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12931-017-0675-x","article-title":"The potential of interleukin-37 as an effective therapeutic agent in asthma","volume":"18","author":"Zhang","year":"2017","journal-title":"Resp. Res."},{"key":"10.1016\/j.cyto.2018.07.027_b0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2018.07.027_b0065","first-page":"795043","article-title":"Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1\/Th2\/Th17-related cytokines","volume":"2015","author":"Xia","year":"2015","journal-title":"Dis. Mark."},{"key":"10.1016\/j.cyto.2018.07.027_b0070","doi-asserted-by":"crossref","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","article-title":"Plasma levels of IL-37 and correlation with TNF-\u03b1, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis","volume":"9","author":"Zhao","year":"2014","journal-title":"PloS One"},{"issue":"5 Suppl. 46","key":"10.1016\/j.cyto.2018.07.027_b0075","first-page":"S4","article-title":"The central role of T cells in rheumatoid arthritis","volume":"25","author":"Cope","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2018.07.027_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11926-009-0052-y","article-title":"Role of IL-17 in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Gaffen","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cyto.2018.07.027_b0085","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","article-title":"IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation","volume":"194","author":"Ye","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.07.027_b0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"Morimoto","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2018.07.027_b0095","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2018.07.027_b0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2018.07.027_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur. Cytok. Netw."},{"key":"10.1016\/j.cyto.2018.07.027_b0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.smim.2013.10.004","article-title":"Interleukin-37","volume":"25","author":"Dinarello","year":"2013","journal-title":"Sem. Immunol"},{"key":"10.1016\/j.cyto.2018.07.027_b0115","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2018.07.027_b0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-5876-12-69","article-title":"IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity","volume":"12","author":"Ye","year":"2014","journal-title":"J. Trans. Med."},{"key":"10.1016\/j.cyto.2018.07.027_b0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2018.07.027_b0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.1994.tb06134.x","article-title":"Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients","volume":"98","author":"Muscat","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2018.07.027_b0135","doi-asserted-by":"crossref","first-page":"e0131992","DOI":"10.1371\/journal.pone.0131992","article-title":"CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis","volume":"10","author":"Cordero","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.07.027_b0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3083.2007.01966.x","article-title":"In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes","volume":"66","author":"Ellingsen","year":"2007","journal-title":"Scand. J. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T05:10:07Z","timestamp":1604725807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618303259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"alternative-id":["S1043466618303259"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.07.027","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}